286 related articles for article (PubMed ID: 29061760)
1. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
Berube BJ; Parish T
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
[TBL] [Abstract][Full Text] [Related]
2. Novel MenA Inhibitors Are Bactericidal against
Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
[No Abstract] [Full Text] [Related]
3. Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.
Chandrasekera NS; Berube BJ; Shetye G; Chettiar S; O'Malley T; Manning A; Flint L; Awasthi D; Ioerger TR; Sacchettini J; Masquelin T; Hipskind PA; Odingo J; Parish T
ACS Infect Dis; 2017 Dec; 3(12):898-916. PubMed ID: 29035551
[TBL] [Abstract][Full Text] [Related]
4. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
5. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
6. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
[TBL] [Abstract][Full Text] [Related]
8. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
[TBL] [Abstract][Full Text] [Related]
9. TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice.
Yu W; Chiwala G; Gao Y; Liu Z; Sapkota S; Lu Z; Guo L; Khan SA; Zhong N; Zhang T
Biomed Pharmacother; 2020 Nov; 131():110782. PubMed ID: 33152940
[TBL] [Abstract][Full Text] [Related]
10. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.
Arora K; Ochoa-Montaño B; Tsang PS; Blundell TL; Dawes SS; Mizrahi V; Bayliss T; Mackenzie CJ; Cleghorn LA; Ray PC; Wyatt PG; Uh E; Lee J; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2014 Nov; 58(11):6962-5. PubMed ID: 25155596
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
[TBL] [Abstract][Full Text] [Related]
12. Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an
de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866874
[TBL] [Abstract][Full Text] [Related]
13. Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis.
Lechartier B; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4457-63. PubMed ID: 25987624
[TBL] [Abstract][Full Text] [Related]
14. A Novel Small-Molecule Inhibitor of the
Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
[TBL] [Abstract][Full Text] [Related]
15. Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.
Lamprecht DA; Finin PM; Rahman MA; Cumming BM; Russell SL; Jonnala SR; Adamson JH; Steyn AJ
Nat Commun; 2016 Aug; 7():12393. PubMed ID: 27506290
[TBL] [Abstract][Full Text] [Related]
16. Loperamide exerts a direct bactericidal effect against M. tuberculosis, M. bovis, M. terrae and M. smegmatis.
Barrientos OM; Juárez E; Gonzalez Y; Castro-Villeda DA; Torres M; Guzmán-Beltrán S
Lett Appl Microbiol; 2021 Mar; 72(3):351-356. PubMed ID: 33220096
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis.
Lu X; Williams Z; Hards K; Tang J; Cheung CY; Aung HL; Wang B; Liu Z; Hu X; Lenaerts A; Woolhiser L; Hastings C; Zhang X; Wang Z; Rhee K; Ding K; Zhang T; Cook GM
ACS Infect Dis; 2019 Feb; 5(2):239-249. PubMed ID: 30485737
[TBL] [Abstract][Full Text] [Related]
18. Identification of 4-Amino-Thieno[2,3-
Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
[TBL] [Abstract][Full Text] [Related]
19. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
O'Malley T; Alling T; Early JV; Wescott HA; Kumar A; Moraski GC; Miller MJ; Masquelin T; Hipskind PA; Parish T
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632008
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds
Li W; Sanchez-Hidalgo A; Jones V; de Moura VC; North EJ; Jackson M
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
